I am upgrading Thermo Fisher Scientific Inc. to a “Buy” with a fair value of $610 per share due to anticipated recovery in the pharma and biotech industries. Thermo Fisher's high-impact ...

Thermo Fisher Scientific (NYSE:TMO) traded lower in the premarket on Wednesday as the Waltham, Massachusetts-based healthcare giant reaffirmed its 2024 revenue outlook after falling short of ...

Analyst Daniel Brennan of TD Cowen maintained a Buy rating on Thermo Fisher (TMO – Research Report), boosting the price target to $686.00. Daniel Brennan has given his Buy rating due to a ...

Thermo Fisher Scientific TMO is preparing to release its quarterly earnings on Wednesday, 2024-10-23. Here's a brief overview of what investors should keep in mind before the announcement.

Thermo Fisher Scientific Inc.'s TMO third-quarter 2024 adjusted earnings per share (EPS) of $5.28 beat the Zacks Consensus Estimate by 0.6%. However, the figure decreased 7.2% year over year.

Guidance: Thermo Fisher reaffirms its 2024 sales guidance of $42.4 billion—$43.3 billion, compared to the consensus of $42.91 billion. The life science company revised its adjusted EPS guidance ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Boston, USA-headquartered essential equipment and chemicals supplier to pharmaceutical industry Thermo Fisher Scientific is setting up a bioprocess design centre (BDC) at Genome Valley ...

(Reuters) - Thermo Fisher Scientific on Wednesday raised the lower end of its annual profit forecast, tweaking it for the third time this year, betting on improved demand for its tools and ...